In a study of histologically proven NAFLD, Verrijken et al. showed that NAFLD severity was independently associated with plasminogen activator inhibitor-1 levels among obese or overweight patients21. The gene discussed is SERPINE1; the disease is metabolic dysfunction-associated steatotic liver disease.